市場調查報告書
商品編碼
1530864
2030 年整形外科器械市場預測:按產品類型、材料類型、分銷管道、最終用戶和地區進行的全球分析Orthopedic Devices Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Distribution Channel, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球整形外科器械市場規模為 637 億美元,預計到 2030 年將達到 878 億美元,預測期內複合年成長率為 5.5%。整形外科器械用於識別、治療和預防影響肌肉骨骼系統的疾病,肌肉骨骼系統由骨骼、關節、韌帶、肌腱和肌肉組成。這些器械對於治療各種整形外科疾病至關重要,包括先天性畸形、關節炎、骨折和運動傷害。這些範圍從簡單的矯正器具和夾板到複雜的外科植入,如髖關節置換術和脊椎融合裝置。整形外科器械不僅可以幫助患者恢復功能和活動能力,還可以透過減輕疼痛和改善生活品質來幫助他們過上更好的生活。
根據世界衛生組織 (WHO) 預測,到 2050 年,全球 60 歲及以上人口預計將達到 21 億。
慢性病增加
該市場直接受到糖尿病和肥胖等慢性病全球成長的影響。骨關節炎在肥胖者中更為常見,因為肥胖會增加關節的機械負荷,尤其是膝蓋和臀部。糖尿病與夏科足等併發症有關,夏科足會削弱足部骨骼,需要進行整形外科手術。此外,生活方式的改變增加了這些慢性病的盛行率,增加了對整形外科治療的需求,例如增加活動能力的脊椎裝置、關節重建和疼痛管理。
設備開發高成本
開發先進的整形外科設備需要在研究、臨床試驗和監管核准方面進行大量投資。為了確保安全性和有效性,對最尖端科技和材料的需求加劇了這種經濟負擔。此外,嚴格的監管標準需要大量的測試,進一步增加了成本。這些高昂的開發成本可能會限制新公司的市場進入、減少創新並導致最終用戶的價格上漲,進而影響整體市場成長。
自訂植入和個人化醫療的開發
由於個人化醫療的趨勢,市場正在擴大。 3D 列印和成像技術的進步使得創建適合患者獨特解剖結構的自訂植入成為可能。透過這種個人化方法,可以實現更好的手術效果、更快的恢復時間和更高的患者滿意度。此外,與患者骨骼結構精確匹配的客製化膝關節和髖植入可以延長設備壽命並降低植入失敗的風險。隨著這些技術的進一步發展,將有更多的商業機會來開發和銷售客製化整形外科解決方案。
強大的價格壓力和市場競爭
術後併發症對整形外科器械市場構成重大威脅,影響病患復健並增加醫療成本。感染疾病、植入失敗和副作用等問題可能導致住院時間延長、額外手術和發病率增加。這些併發症不僅影響病患的治療效果,也影響整形外科器械製造商的聲譽和財務表現。
由於醫療保健系統專注於應對 COVID-19 病例激增,推遲了關節關節重建等非緊急整形外科手術,這推動了整形外科器械市場在 COVID-19 大流行期間的上漲,這對市場產生了巨大影響。結果,在疫情最嚴重的時候,整形外科器械市場出現了顯著下降。此外,供應鏈中斷進一步複雜化了生產和分銷,影響了零件和原料的可用性。
預計聯合重組設備領域在預測期內將是最大的。
在整形外科器械市場中,聯合重組器械細分市場佔據最大的市場佔有率。隨著骨關節炎、類風濕性關節炎等關節相關疾病越來越常見,尤其是人口老化,髖關節、膝關節關節重建等關節重建置換術的需求量很大,這也是其優越性的主要原因。此外,關節重組技術的開拓,包括開發更俱生物相容性和持久性的材料、微創手術的採用以及自訂植入的日益普及,正在推動該市場的進一步成長。
預計聚合物產業在預測期內複合年成長率最高。
預計在預測期內,聚合物細分市場將在整形外科市場中實現最高的年複合成長率。這種成長是由於先進聚合物材料由於其卓越的生物相容性、靈活性和耐用性而在整形外科植入和設備中擴大採用所推動的。聚合物技術的創新有助於開發輕質、高效能的設備,進而改善患者的治療效果。此外,對微創外科手術的需求不斷成長以及世界人口的老化進一步促進了這一領域的快速擴張。
北美在整形外科器械市場中佔最大佔有率。該地區整形外科疾病盛行率高、醫療研發投入龐大、醫療基礎設施完善是該地區優勢的關鍵因素。美國人口老化、醫療保健系統發達以及對尖端整形外科解決方案的高需求,是這一佔有率的主要貢獻者。此外,頂級整形外科器械製造商的存在和保險計劃的大力支持進一步加強了北美的市場領導地位。
整形外科器械市場以亞太地區最高的複合年成長率擴張。造成這種快速成長的因素有很多,包括人口成長、整形外科疾病發生頻率的增加以及中國和印度等國家醫療保健系統的發展。該地區對整形外科器械需求的增加也歸因於醫療設施的發展、醫療保健成本的上升以及對整形外科健康的更好了解。此外,亞太市場的顯著成長軌跡也歸功於國際參與者的湧入。
According to Stratistics MRC, the Global Orthopedic Devices Market is accounted for $63.7 billion in 2024 and is expected to reach $87.8 billion by 2030, growing at a CAGR of 5.5% during the forecast period. Orthopedic devices are used to identify, treat, and prevent diseases that impact the musculoskeletal system, which is made up of the bones, joints, ligaments, tendons, and muscles. These tools are vital for treating a wide range of orthopedic ailments, including congenital malformations, arthritis, fractures, and sports injuries. Simple braces and splints to intricate surgical implants like hip replacements and spinal fusion machines are among them. Orthopedic devices help patients live better lives by reducing pain and enhancing their quality of life, in addition to helping them regain function and mobility.
According to the World Health Organization (WHO), the global population aged 60 years and older is expected to reach 2.1 billion by 2050.
Growing rate of chronic illnesses
The market is directly impacted by the rise in chronic illnesses like diabetes and obesity that are occurring worldwide. Osteoarthritis is more common in obese people because obesity increases the mechanical load on joints, especially the knees and hips. Diabetes has been linked to complications like Charcot foot, a condition where the foot's bones weaken and necessitate orthopedic device surgery. Additionally, the prevalence of these chronic conditions is rising as a result of changes in lifestyle, and this is driving up demand for orthopedic treatments like spinal devices, joint replacement surgery, and pain management to increase mobility.
High costs of device development
Developing advanced orthopedic devices involves substantial investments in research, clinical trials, and regulatory approvals. This financial burden is amplified by the need for cutting-edge technology and materials to ensure safety and efficacy. Additionally, stringent regulatory standards necessitate extensive testing, further increasing costs. These high development expenses can limit market entry for new companies, reduce innovation, and lead to higher prices for end-users, thereby impacting overall market growth.
Developments in custom implants and personalized medicine
The market is expanding due to the trend toward personalized medicine. Custom implants that are made to fit each patient's unique anatomy are now possible, due to developments in 3D printing and imaging technologies. Better surgical results, quicker recovery periods, and increased patient satisfaction are all possible with this individualized approach. Additionally, bespoke knee and hip implants that precisely match the bone structure of the patient can lengthen the device's lifespan and lower the risk of implant failure. Opportunities for businesses to create and sell customized orthopedic solutions will increase as these technologies develop further.
Strong pricing pressures and market competition
Post-surgical complications pose a significant threat to the orthopedic devices market, impacting patient recovery and increasing healthcare costs. Issues such as infections, implant failures, and adverse reactions can lead to prolonged hospital stays, additional surgeries, and increased morbidity. These complications not only hinder patient outcomes but also affect the reputation and financial performance of orthopedic device manufacturers.
The postponement of elective surgeries, such as joint replacements and other non-emergency orthopedic procedures, as healthcare systems concentrated on managing the surge of COVID-19 cases, had a significant impact on the orthopedic devices market during the COVID-19 pandemic. As a result, at the height of the pandemic, there was a notable drop in the market for orthopedic devices. Moreover, production and distribution were made even more difficult by supply chain interruptions, which also had an impact on the availability of components and raw materials.
The joint reconstruction devices segment is expected to be the largest during the forecast period
In the orthopedic devices market, the joint reconstruction devices segment has the largest market share. As osteoarthritis, rheumatoid arthritis, and other joint-related disorders are becoming more common, especially in the aging population, there is a high demand for joint replacement surgeries, such as hip and knee replacements, which is the main cause of this dominance. Additionally, this market has grown even more as a result of technological developments in joint reconstruction, such as the creation of biocompatible and longer-lasting materials, the use of less invasive surgery, and the increasing popularity of customized implants.
The polymers segment is expected to have the highest CAGR during the forecast period
The polymers segment is anticipated to achieve the highest compound annual growth rate in the orthopedic devices market during the forecast period. This growth is driven by the increasing adoption of advanced polymer materials in orthopedic implants and devices due to their superior biocompatibility, flexibility, and durability. Innovations in polymer technology enable the development of lightweight, high-performance devices that enhance patient outcomes. Additionally, the rising demand for minimally invasive surgical procedures and the aging global population further contribute to the segment's rapid expansion.
In the orthopedic devices market, North America commands the largest share. The region's high incidence of orthopedic disorders, substantial investment in medical R&D, and sophisticated healthcare infrastructure are the main factors contributing to its dominance. With a large aging population, a strong healthcare system, and a high demand for cutting-edge orthopedic solutions, the U.S. in particular contributes significantly to this share. Moreover, the market leadership of North America is further strengthened by the existence of top orthopedic device manufacturers and robust support from insurance systems.
The orthopedic devices market is expanding at the highest CAGR in the Asia-Pacific region. Numerous factors, such as the growing population, the rise in the frequency of orthopedic conditions, and the development of the healthcare system in nations like China and India, are responsible for this quick growth. The rise in demand for orthopedic devices in the area is also attributed to the development of healthcare facilities, the rising cost of medical care, and a greater understanding of orthopedic health. Furthermore, the remarkable growth trajectory of the Asia-Pacific market can also be attributed to the influx of international players.
Key players in the market
Some of the key players in Orthopedic Devices market include Arthrex, B. Braun Melsungen AG, Conmed Corporation, Enovis Corporation, Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson (DePuy Synthes), Medtronic plc, NuVasive, Orthofix, OrthoPediatrics, Ossur, Paragon 28, Smith & Nephew, Stryker Corporation, Think Surgical and Zimmer Biomet.
In September 2023, Globus Medical Inc. GMED recently announced that it has successfully closed the previously announced merger with NuVasive. The combined firm will offer one of the most extensive selections of musculoskeletal procedural solutions, enabling technology to influence the care continuum for surgeons and patients.
In September 2023, US-based orthopedics company Enovis has announced plans to acquire surgical implant maker LimaCorporate S.p.A (Lima), to expand its global reach and portfolio of products. Under the terms of the agreement, Enovis will obtain Italy-based Lima in a transaction valued at €800 million ($847 million) made up of a cash payment of €700 million, and €100 million in shares of Enovis common stock, issued within 18 months after closing.
In June 2023, Arterex, a medical device contract manufacturer, has signed an agreement to acquire NextPhase Medical Devices for an undisclosed amount. NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices, and single use disposables in North America.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.